Have you heard the term Adiposity-Based Chronic Disease (ABCD) before
GLP-1 drugs and reduction of cancer Among ~1.6 million people w/ T2 diabetes, for GLP-1 drugs vs insulin Rx, there was less risk for 11 of the 13 cancers associated with obesity I would question the initial interpretation - how about: Among ~1.6 million people with T2 diabetes, those using insulin showed higher rates of certain cancers compared to those using GLP-1 drugs
Over time, this can lead to conditions like Barretts esophagus or severe acid reflux (GERD)
Metabolism, 57(5), 712-717
Both systolic and diastolic blood pressure decreased in all treatments at 24 weeks
In fact, FDA labels for these medications include warnings about acute kidney injury risk, particularly when dehydration occurs from severe gastrointestinal adverse events